Skip to main content
SpringerLink
Log in

Clinical experience with Hemofil M in a hemophilia patient exhibiting inhibitors

  • Symposium
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Scheibel E, Ingerslev J (1991) Treatment of hemophilic factor VIII inhibitors with high doses of factor VIII. A follow-up (abstract). Abstract Book. XIX International Congress of The World Federation of Hemophilia, Washington 1990

  2. Scheibel E, Ingerslev J, Dalsgard-Nielsen J, Stenbjerg S, Knudsen JB, Danish Study Group (1987) Continuous high-dose factor VIII for the induction of immune tolerance in haemophilia A patients with high responder state: a description of eleven patients treated. Thromb Haemost 58: 1049–1052

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Immunology, Hemophilia Centre, University Hospital Skejby, DK-8200, Aarhus N, Denmark

    J. Ingerslev & K. Wallevik

Authors
  1. J. Ingerslev
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Wallevik
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ingerslev, J., Wallevik, K. Clinical experience with Hemofil M in a hemophilia patient exhibiting inhibitors. Ann Hematol 63, 152–154 (1991). https://doi.org/10.1007/BF01703247

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01703247

Keywords

Search

Navigation